News & Events

2006 Press Releases

Eidogen-Sertanty licenses discovery informatics software and databases to Cephalon

San Diego, CA (January 5, 2006) - Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced today that Cephalon, Inc. (Nasdaq: CEPH), a Pennsylvania-based biopharmaceutical company, will access Eidogen-Sertanty’s Kinase Knowledgebase (KKB™), Target Informatics Platform™ (TIP™), and EVE™™ Comparative Visualization software.

Scientists at Cephalon will use the proprietary software to support small molecule drug discovery projects in their neurology and oncology therapeutic programs.

"We are pleased to provide Cephalon with broad access to several of our discovery informatics products. We're confident that our kinase informatics and structural informatics solutions will help the experienced research team at Cephalon accelerate their lead discovery efforts," said Dr. Steve Muskal, CEO of Eidogen-Sertanty.

For more information, please contact:

Steve Muskal

About Eidogen-Sertanty, Inc.

Eidogen-Sertanty is a privately held company that is dedicated to helping scientists discover new medicines with innovative software technology and knowledgebases. To find out more about Eidogen-Sertanty please visit